Characterization of the Activities of Dinuclear Thiolato-Bridged Arene Ruthenium Complexes against Toxoplasma gondii
- 1 September 2017
- journal article
- research article
- Published by American Society for Microbiology in Antimicrobial Agents and Chemotherapy
- Vol. 61 (9) , e01031-17
Abstract
The in vitro effects of 18 dinuclear thiolato-bridged arene ruthenium complexes (1 monohiolato compound, 4 dithiolato compounds, and 13 trithiolato compounds), originally designed as anticancer agents, on the apicomplexan parasite Toxoplasma gondii grown in human foreskin fibroblast (HFF) host cells were studied. Some trithiolato compounds exhibited antiparasitic efficacy at concentrations of 250 nM and below. Among those, complex 1 and complex 2 inhibited T. gondii proliferation with 50% inhibitory concentrations (IC 50 s) of 34 and 62 nM, respectively, and they did not affect HFFs at dosages of 200 μM or above, resulting in selectivity indices of >23,000. The IC 50 s of complex 9 were 1.2 nM for T. gondii and above 5 μM for HFFs. Transmission electron microscopy detected ultrastructural alterations in the matrix of the parasite mitochondria at the early stages of treatment, followed by a more pronounced destruction of tachyzoites. However, none of the three compounds applied at 250 nM for 15 days was parasiticidal. By affinity chromatography using complex 9 coupled to epoxy-activated Sepharose followed by mass spectrometry, T. gondii translation elongation factor 1α and two ribosomal proteins, RPS18 and RPL27, were identified to be potential binding proteins. In conclusion, organometallic ruthenium complexes exhibit promising activities against Toxoplasma , and the potential mechanisms of action of these compounds as well as their prospective applications for the treatment of toxoplasmosis are discussed.Keywords
Funding Information
- Swiss National Science Foundation (PP00P2_133568)
- Swiss National Science Foundation (PP00P2_157545)
- Swiss National Science Foundation (310030_165782)
- University of Bern (UniBE-ID)
- University of Zurich (UniZH)
- UBS Promedica Foundation (UBS)
- Novartis Jubilee Foundation (Novartis)
- ANR (ANR-10-IDEX-0001-02 PSL)
- Swiss National Science Foundation (CRSII5_173718)
This publication has 76 references indexed in Scilit:
- Molecular and Cellular Characterization of the Biological Effects of Ruthenium(II) Complexes Incorporating 2-Pyridyl-2-pyrimidine-4-carboxylic AcidJournal of the American Chemical Society, 2012
- Searching for New Chemotherapies for Tropical Diseases: Ruthenium–Clotrimazole Complexes Display High in Vitro Activity againstLeishmania majorandTrypanosoma cruziand Low Toxicity toward Normal Mammalian CellsJournal of Medicinal Chemistry, 2012
- Thiolato‐Bridged Arene–Ruthenium Complexes: Synthesis, Molecular Structure, Reactivity, and Anticancer Activity of the Dinuclear Complexes [(arene)2Ru2(SR)2Cl2]European Journal of Inorganic Chemistry, 2011
- The adaptive potential of a survival artist: characterization of thein vitrointeractions ofToxoplasma gondiitachyzoites with di-cationic compounds in human fibroblast cell culturesParasitology, 2011
- Organometallic Anticancer CompoundsJournal of Medicinal Chemistry, 2010
- New trends for metal complexes with anticancer activityCurrent Opinion in Chemical Biology, 2008
- Elongation factor 1a mediates the specificity of mitochondrial tRNA import in T. bruceiThe EMBO Journal, 2007
- C-Raf antagonizes apoptosis induced by IFN-α in human lung cancer cells by phosphorylation and increase of the intracellular content of elongation factor 1ACell Death & Differentiation, 2007
- Mitochondrial tRNA Import in Toxoplasma gondiiJournal of Biological Chemistry, 2004
- Genomic organization and expression of elongation factor-1α genes in Trypanosoma bruceiMolecular and Biochemical Parasitology, 1996